CDK4 and thyroid cancer: To summarize, the upregulation of Cyclins D with stabilization of activated (T172-phosphorylated) CDK4 complexes and the upregulation of Cyclin E1 with increase of its kinase activity are most probably the mechanisms that bypass CDK4/6 inhibition in thyroid cancer cells.